The frequencies of CD38+CD43+ cells among CD19+ B cells were significantly elevated in active SLE than healthy controls (Figure 1B) and significantly reduced after intensification of the immunosuppressive therapy for active SLE and correlated with SLEDAI scores (Supplementary Figure 1). Here, CD19 is linked to systemic lupus erythematosus.